Constellation Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 09, 2018
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $100,000,000
Company Info
- Founders
- Jigar Raythatha
- Company Description
- Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
- Market
- Cancer treatment
- Location
- Cambridge, MA, USA
- Coinvestors
- Cormorant Asset Management, Deerfield Management Company, L.P., Fidelity Investments, Hillhouse Capital Group, NS Investment, OrbiMed Advisors, Sirona Capital, SR One, The Column Group, Third Rock Ventures, University of California, Venrock